Litcius/Paper detail

Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes

Jong Chul Park, Julia Durbeck, John R. Clark, Daniel L. Faden

2020Oral Oncology18 citationsDOI

Topics & Concepts

CetuximabMedicineHead and neck squamous-cell carcinomaOncologyInternal medicineRegimenHead and neck cancerCancerColorectal cancerHead and Neck Cancer StudiesCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas
Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes | Litcius